Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 159

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Long-term prognosis of patients with pediatric pheochromocytoma

Open access
Bausch, Birke, Wellner, Ulrich, Bausch, Dirk, Schiavi, Francesca, Barontini, Marta, Sanso, Gabriela, Walz, Martin K, Peczkowska, Mariola, Weryha, Georges, Dall'Igna, Patrizia, Cecchetto, Giovanni, Bisogno, Gianni, Moeller, Lars C, Bockenhauer, Detlef, Patocs, Attila, Rácz, Karoly, Zabolotnyi, Dmitry, Yaremchuk, Svetlana, Dzivite-Krisane, Iveta, Castinetti, Frederic, Taieb, David, Malinoc, Angelica, von Dobschuetz, Ernst, Roessler, Jochen, Schmid, Kurt W, Opocher, Giuseppe, Eng, Charis, Neumann, Hartmut P H · 2014 · Endocrine-Related Cancer

Abstract

A third of patients with paraganglial tumors, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes,RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127, and MAX. Despite increasing importance, data for long-term prognosis are scarce in pediatric presentations. The European-American-Pheochromocytoma–Paraganglioma-Registry, with a total of 2001 patients with confirmed paraganglial tumors, was the platform for this study. Molecular genetic and phenotypic classification and assessment of gene-specific long-term outcome with second and/or malignant paraganglial tumors and life expectancy were performed in patients diagnosed at <18 years. Of 177 eligible registrants, 80% had mutations, 49%VHL, 15%SDHB, 10%SDHD, 4%NF1, and one patient each in RET, SDHA, and SDHC. A second primary paraganglial tumor developed in 38% with increasing frequency over time, reaching 50% at 30 years after initial diagnosis. Their prevalence was associated with hereditary disease (P=0.001), particularly in VHL and SDHD mutation carriers (VHL vs others,P=0.001 and SDHD vs others,P=0.042). A total of 16 (9%) patients with hereditary disease had malignant tumors, ten at initial diagnosis and another six during follow-up. The highest prevalence was associated with SDHB(SDHB vs others,P<0.001). Eight patients died (5%), all of whom had germline mutations. Mean life expectancy was 62 years with hereditary disease. Hereditary disease and the underlying germline mutation define the long-term prognosis of pediatric patients in terms of prevalence and time of second primaries, malignant transformation, and survival. Based on these data, gene-adjusted, specific surveillance guidelines can help effective preventive medicine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/erc-13-0415

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 159

Metadata

Authors
Bausch, B., Wellner, U., Bausch, D., Schiavi, F., Barontini, M., Sanso, G., Walz, M. K., Peczkowska, M., Weryha, G., Dall'Igna, P., Cecchetto, G., Bisogno, G., Moeller, L. C., Bockenhauer, D., Patocs, A., Rácz, K., Zabolotnyi, D., Yaremchuk, S., Dzivite-Krisane, I., Castinetti, F., Taieb, D., Malinoc, A., von Dobschuetz, E., Roessler, J., Schmid, K. W., Opocher, G., Eng, C., & Neumann, H. P. H.
Venue
Endocrine-Related Cancer
Published
2013-10-29
Volume
21
Issue
1
Pages
17-25
ISSN
  • 1351-0088 (ISSN-L)
  • 1479-6821
OpenAlex
W2140559519
Cited by
159
References
2
FWCI
6.29
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.